Julie Chao - Publications

Affiliations: 
Medical University of South Carolina, Charleston, SC, United States 
Area:
Biochemistry

149 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Chao J, Guo Y, Chao L. Protective Role of Endogenous Kallistatin in Vascular Injury and Senescence by Inhibiting Oxidative Stress and Inflammation. Oxidative Medicine and Cellular Longevity. 2018: 4138560. PMID 30622668 DOI: 10.1155/2018/4138560  0.76
2018 Yao Y, Li B, Liu C, Fu C, Li P, Guo Y, Ma G, Liu N, Chao L, Chao J. Reduced Plasma Kallistatin Is Associated With the Severity of Coronary Artery Disease, and Kallistatin Treatment Attenuates Atherosclerotic Plaque Formation in Mice. Journal of the American Heart Association. 7: e009562. PMID 30554563 DOI: 10.1161/JAHA.118.009562  0.76
2018 Guo Y, Chao L, Chao J. Kallistatin attenuates endothelial senescence by modulating Let-7g-mediated miR-34a-SIRT1-eNOS pathway. Journal of Cellular and Molecular Medicine. PMID 29992759 DOI: 10.1111/jcmm.13734  0.76
2017 Chao J, Guo Y, Li P, Chao L. Opposing Effects of Oxygen Regulation on Kallistatin Expression: Kallistatin as a Novel Mediator of Oxygen-Induced HIF-1-eNOS-NO Pathway. Oxidative Medicine and Cellular Longevity. 2017: 5262958. PMID 29387292 DOI: 10.1155/2017/5262958  0.76
2017 Chao J, Guo Y, Li P, Chao L. Role of Kallistatin Treatment in Aging and Cancer by Modulating miR-34a and miR-21 Expression. Oxidative Medicine and Cellular Longevity. 2017: 5025610. PMID 28744338 DOI: 10.1155/2017/5025610  0.76
2017 Chao J, Li P, Chao L. Kallistatin: double-edged role in angiogenesis, apoptosis and oxidative stress. Biological Chemistry. PMID 28742513 DOI: 10.1515/hsz-2017-0180  0.76
2017 Guo Y, Li P, Gao L, Zhang J, Yang Z, Bledsoe G, Chang E, Chao L, Chao J. Kallistatin reduces vascular senescence and aging by regulating microRNA-34a-SIRT1 pathway. Aging Cell. PMID 28544111 DOI: 10.1111/acel.12615  0.76
2017 Lin WC, Chen CW, Chao L, Chao J, Lin YS. Plasma kallistatin in critically ill patients with severe sepsis and septic shock. Plos One. 12: e0178387. PMID 28542440 DOI: 10.1371/journal.pone.0178387  0.76
2017 Chao J, Li P, Chao L. Kallistatin suppresses cancer development by multi-factorial actions. Critical Reviews in Oncology/Hematology. 113: 71-78. PMID 28427524 DOI: 10.1016/j.critrevonc.2017.03.011  0.76
2016 Chao J, Bledsoe G, Chao L. Protective Role of Kallistatin in Vascular and Organ Injury. Hypertension. PMID 27432868 DOI: 10.1161/HYPERTENSIONAHA.116.07861  0.36
2016 Li P, Guo Y, Bledsoe G, Yang Z, Chao L, Chao J. Kallistatin Induces Breast Cancer Cell Apoptosis and Autophagy by Modulating Wnt Signaling and microRNA Synthesis. Experimental Cell Research. PMID 26790955 DOI: 10.1016/j.yexcr.2016.01.004  0.76
2015 Wang Y, Chen CL, Pan QZ, Wu YY, Zhao JJ, Jiang SS, Chao J, Zhang XF, Zhang HX, Zhou ZQ, Tang Y, Huang XQ, Zhang JH, Xia JC. Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma. Oncotarget. PMID 26575170 DOI: 10.18632/oncotarget.6319  0.4
2015 Zhang XF, Chao J, Pan QZ, Pan K, Weng DS, Wang QJ, Zhao JJ, He J, Liu Q, Jiang SS, Chen CL, Zhang HX, Xia JC. Overexpression of WWP1 Promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma. Oncotarget. PMID 26506518 DOI: 10.18632/oncotarget.5712  0.4
2015 Zhu T, Yao Q, Hu X, Chen C, Yao H, Chao J. The Role of MCPIP1 in Ischemia/Reperfusion Injury-Induced HUVEC Migration and Apoptosis. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 37: 577-591. PMID 26329288 DOI: 10.1159/000430378  0.52
2015 Lin WC, Chen CW, Huang YW, Chao L, Chao J, Lin YS, Lin CF. Kallistatin protects against sepsis-related acute lung injury via inhibiting inflammation and apoptosis. Scientific Reports. 5: 12463. PMID 26198099 DOI: 10.1038/srep12463  0.76
2015 Guo Y, Li P, Bledsoe G, Yang ZR, Chao L, Chao J. Kallistatin inhibits TGF-β-induced endothelial-mesenchymal transition by differential regulation of microRNA-21 and eNOS expression. Experimental Cell Research. 337: 103-10. PMID 26156753 DOI: 10.1016/j.yexcr.2015.06.021  0.76
2015 Leu CH, Yang ML, Chung NH, Huang YJ, Su YC, Chen YC, Lin CC, Shieh GS, Chang MY, Wang SW, Chang Y, Chao J, Chao L, Wu CL, Shiau AL. Kallistatin Ameliorates Influenza Virus Pathogenesis by Inhibition of Kallikrein-Related Peptidase 1-Mediated Cleavage of Viral Hemagglutinin. Antimicrobial Agents and Chemotherapy. PMID 26149981 DOI: 10.1128/AAC.00065-15  0.36
2015 Li P, Guo Y, Bledsoe G, Yang ZR, Fan H, Chao L, Chao J. Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis. Critical Care (London, England). 19: 200. PMID 25930108 DOI: 10.1186/s13054-015-0919-4  0.76
2015 Hsieh YH, Liu KK, Sulake RS, Chao JI, Chen C. Microwave-assisted efficient conjugation of nanodiamond and paclitaxel. Bioorganic & Medicinal Chemistry Letters. 25: 2074-7. PMID 25890802 DOI: 10.1016/j.bmcl.2015.03.089  0.48
2014 Yin KH, Hsieh YH, Sulake RS, Wang SP, Chao JI, Chen C. Optimization of gefitinib analogues with potent anticancer activity. Bioorganic & Medicinal Chemistry Letters. 24: 5247-50. PMID 25305687 DOI: 10.1016/j.bmcl.2014.09.056  0.52
2014 Chao J, Bledsoe G, Chao L. Kallikrein-kinin in stem cell therapy. World Journal of Stem Cells. 6: 448-57. PMID 25258666 DOI: 10.4252/wjsc.v6.i4.448  0.76
2014 Gao L, Li P, Zhang J, Hagiwara M, Shen B, Bledsoe G, Chang E, Chao L, Chao J. Novel role of kallistatin in vascular repair by promoting mobility, viability, and function of endothelial progenitor cells. Journal of the American Heart Association. 3: e001194. PMID 25237049 DOI: 10.1161/JAHA.114.001194  0.76
2014 Chao J, Bledsoe G, Chao L. Tissue kallikrein-kinin therapy in hypertension and organ damage. Progress in Drug Research. Fortschritte Der Arzneimittelforschung. ProgrèS Des Recherches Pharmaceutiques. 69: 37-57. PMID 25130039  0.76
2014 Palanisamy AP, Cheng G, Sutter AG, Liu J, Lewin DN, Chao J, Chavin K. Adenovirus-mediated eNOS expression augments liver injury after ischemia/reperfusion in mice. Plos One. 9: e93304. PMID 24667691 DOI: 10.1371/journal.pone.0093304  0.76
2014 Li P, Bledsoe G, Yang ZR, Fan H, Chao L, Chao J. Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsis. Immunology. 142: 216-26. PMID 24467264 DOI: 10.1111/imm.12242  0.76
2013 Yang CR, Liao WS, Wu YH, Murugan K, Chen C, Chao JI. CR108, a novel vitamin K3 derivative induces apoptosis and breast tumor inhibition by reactive oxygen species and mitochondrial dysfunction. Toxicology and Applied Pharmacology. 273: 611-22. PMID 24128853 DOI: 10.1016/j.taap.2013.10.007  0.52
2013 Lu SL, Tsai CY, Luo YH, Kuo CF, Lin WC, Chang YT, Wu JJ, Chuang WJ, Liu CC, Chao L, Chao J, Lin YS. Kallistatin modulates immune cells and confers anti-inflammatory response to protect mice from group A streptococcal infection. Antimicrobial Agents and Chemotherapy. 57: 5366-72. PMID 23959316 DOI: 10.1128/AAC.00322-13  0.76
2013 Guo DH, Parikh SJ, Chao J, Pollock NK, Wang X, Snieder H, Navis G, Wilson JG, Bhagatwala J, Zhu H, Dong Y. Urinary prostasin excretion is associated with adiposity in nonhypertensive African-American adolescents. Pediatric Research. 74: 206-10. PMID 23863785 DOI: 10.1038/pr.2013.81  0.76
2013 Gao L, Bledsoe G, Yin H, Shen B, Chao L, Chao J. Tissue kallikrein-modified mesenchymal stem cells provide enhanced protection against ischemic cardiac injury after myocardial infarction. Circulation Journal : Official Journal of the Japanese Circulation Society. 77: 2134-44. PMID 23697984 DOI: DN/JST.JSTAGE/circj/CJ-12-1585  0.76
2013 Zhang J, Yang Z, Li P, Bledsoe G, Chao L, Chao J. Kallistatin antagonizes Wnt/β-catenin signaling and cancer cell motility via binding to low-density lipoprotein receptor-related protein 6. Molecular and Cellular Biochemistry. 379: 295-301. PMID 23666756 DOI: 10.1007/s11010-013-1654-2  0.76
2013 Yao YY, Fu C, Ma GS, Feng Y, Shen CX, Wu GQ, Zhang XG, Ding JD, Tang CC, Chen Z, Dai QM, Tong JY, Luo D, Zhu J, Zhi H, ... ... Chao J, et al. Tissue kallikrein is related to the severity of coronary artery disease. Clinica Chimica Acta; International Journal of Clinical Chemistry. 423: 90-8. PMID 23639635 DOI: 10.1016/j.cca.2013.04.017  0.76
2013 Yao Y, Sheng Z, Li Y, Fu C, Ma G, Liu N, Chao J, Chao L. Tissue kallikrein-modified human endothelial progenitor cell implantation improves cardiac function via enhanced activation of akt and increased angiogenesis. Laboratory Investigation; a Journal of Technical Methods and Pathology. 93: 577-91. PMID 23508045 DOI: 10.1038/labinvest.2013.48  0.76
2013 Lin WC, Lu SL, Lin CF, Chen CW, Chao L, Chao J, Lin YS. Plasma kallistatin levels in patients with severe community-acquired pneumonia. Critical Care (London, England). 17: R27. PMID 23394256 DOI: 10.1186/cc12507  0.76
2013 Zhu H, Chao J, Kotak I, Guo D, Parikh SJ, Bhagatwala J, Dong Y, Patel SY, Houk C, Chao L, Dong Y. Plasma kallistatin is associated with adiposity and cardiometabolic risk in apparently healthy African American adolescents. Metabolism: Clinical and Experimental. 62: 642-6. PMID 23190873 DOI: 10.1016/j.metabol.2012.10.012  0.76
2012 Liu Y, Bledsoe G, Hagiwara M, Shen B, Chao L, Chao J. Depletion of endogenous kallistatin exacerbates renal and cardiovascular oxidative stress, inflammation, and organ remodeling. American Journal of Physiology. Renal Physiology. 303: F1230-8. PMID 22811485 DOI: 10.1152/ajprenal.00257.2012  0.76
2012 Patel AB, Chao J, Palmer LG. Tissue kallikrein activation of the epithelial Na channel. American Journal of Physiology. Renal Physiology. 303: F540-50. PMID 22622459 DOI: 10.1152/ajprenal.00133.2012  0.76
2012 Tseng HH, Chuah QY, Yang PM, Chen CT, Chao JC, Lin MD, Chiu SJ. Securin enhances the anti-cancer effects of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075) in human colorectal cancer cells. Plos One. 7: e36006. PMID 22563433 DOI: 10.1371/journal.pone.0036006  0.36
2012 Cheng CW, Wang HW, Chang CW, Chu HW, Chen CY, Yu JC, Chao JI, Liu HF, Ding SL, Shen CY. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer. Breast Cancer Research and Treatment. 134: 1081-93. PMID 22476851 DOI: 10.1007/s10549-012-2034-4  0.4
2012 Yao Y, Sheng Z, Li Y, Yan F, Fu C, Li Y, Ma G, Liu N, Chao J, Chao L. Tissue kallikrein promotes cardiac neovascularization by enhancing endothelial progenitor cell functional capacity. Human Gene Therapy. 23: 859-70. PMID 22435954 DOI: 10.1089/hum.2011.123  0.76
2012 Leung TK, Chen CH, Lai CH, Lee CM, Chen CC, Yang JC, Chen KC, Chao JS. Bone and joint protection ability of ceramic material with biological effects. The Chinese Journal of Physiology. 55: 47-54. PMID 22242954 DOI: 10.4077/CJP.2012.AMM113  0.8
2012 Leung TK, Huang PJ, Sun LM, Chu JS, Chen CS, Lee CM, Wu CH, Chao JS. Silicone breast implant with intracapsular rupture coexisting with locally advanced carcinoma. The Breast Journal. 18: 76-7. PMID 22060279 DOI: 10.1111/j.1524-4741.2011.01187.x  0.8
2011 Tsai CC, Liu HF, Hsu KC, Yang JM, Chen C, Liu KK, Hsu TS, Chao JI. 7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel ROCK inhibitor blocks cytoskeleton function and cell migration. Biochemical Pharmacology. 81: 856-65. PMID 21276421 DOI: 10.1016/j.bcp.2011.01.009  0.52
2010 Leung TK, Huang PJ, Lee CM, Chen CS, Wu CH, Chao JS. Can breast magnetic resonance imaging demonstrate characteristic findings of preoperative ductal carcinoma in situ in Taiwanese women? Asian Journal of Surgery / Asian Surgical Association. 33: 143-9. PMID 21163412 DOI: 10.1016/S1015-9584(10)60024-3  0.8
2010 Shen B, Gao L, Hsu YT, Bledsoe G, Hagiwara M, Chao L, Chao J. Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signaling. American Journal of Physiology. Heart and Circulatory Physiology. 299: H1419-27. PMID 20729399 DOI: 10.1152/ajpheart.00591.2010  0.76
2010 Liu KK, Zheng WW, Wang CC, Chiu YC, Cheng CL, Lo YS, Chen C, Chao JI. Covalent linkage of nanodiamond-paclitaxel for drug delivery and cancer therapy. Nanotechnology. 21: 315106. PMID 20634575 DOI: 10.1088/0957-4484/21/31/315106  0.52
2010 Yin H, Gao L, Shen B, Chao L, Chao J. Kallistatin inhibits vascular inflammation by antagonizing tumor necrosis factor-alpha-induced nuclear factor kappaB activation. Hypertension. 56: 260-7. PMID 20566960 DOI: 10.1161/HYPERTENSIONAHA.110.152330  0.76
2010 Shiau AL, Teo ML, Chen SY, Wang CR, Hsieh JL, Chang MY, Chang CJ, Chao J, Chao L, Wu CL, Lee CH. Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin. Bmc Cancer. 10: 245. PMID 20509975 DOI: 10.1186/1471-2407-10-245  0.76
2010 Gao L, Smith RS, Chen LM, Chai KX, Chao L, Chao J. Tissue kallikrein promotes prostate cancer cell migration and invasion via a protease-activated receptor-1-dependent signaling pathway. Biological Chemistry. 391: 803-12. PMID 20482314 DOI: 10.1515/BC.2010.084  0.76
2010 Chao J, Shen B, Gao L, Xia CF, Bledsoe G, Chao L. Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing. Biological Chemistry. 391: 345-55. PMID 20180644 DOI: 10.1515/BC.2010.042  0.76
2010 White NM, Bui A, Mejia-Guerrero S, Chao J, Soosaipillai A, Youssef Y, Mankaruos M, Honey RJ, Stewart R, Pace KT, Sugar L, Diamandis EP, Doré J, Yousef GM. Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs. Biological Chemistry. 391: 411-23. PMID 20180642 DOI: 10.1515/BC.2010.041  0.76
2010 Liu Y, Bledsoe G, Hagiwara M, Yang ZR, Shen B, Chao L, Chao J. Blockade of endogenous tissue kallikrein aggravates renal injury by enhancing oxidative stress and inhibiting matrix degradation. American Journal of Physiology. Renal Physiology. 298: F1033-40. PMID 20089675 DOI: 10.1152/ajprenal.00518.2009  0.76
2010 Shen B, Chao L, Chao J. Pivotal role of JNK-dependent FOXO1 activation in downregulation of kallistatin expression by oxidative stress. American Journal of Physiology. Heart and Circulatory Physiology. 298: H1048-54. PMID 20081110 DOI: 10.1152/ajpheart.00826.2009  0.76
2010 Gao L, Chao L, Chao J. A novel signaling pathway of tissue kallikrein in promoting keratinocyte migration: activation of proteinase-activated receptor 1 and epidermal growth factor receptor. Experimental Cell Research. 316: 376-89. PMID 19879874 DOI: 10.1016/j.yexcr.2009.10.022  0.76
2009 Hsieh JL, Shen PC, Shiau AL, Jou IM, Lee CH, Teo ML, Wang CR, Chao J, Chao L, Wu CL. Adenovirus-mediated kallistatin gene transfer ameliorates disease progression in a rat model of osteoarthritis induced by anterior cruciate ligament transection. Human Gene Therapy. 20: 147-58. PMID 20377366 DOI: 10.1089/hum.2008.096  0.76
2009 Shen B, Smith RS, Hsu YT, Chao L, Chao J. Kruppel-like factor 4 is a novel mediator of Kallistatin in inhibiting endothelial inflammation via increased endothelial nitric-oxide synthase expression. The Journal of Biological Chemistry. 284: 35471-8. PMID 19858207 DOI: 10.1074/jbc.M109.046813  0.76
2009 Smith RS, Gao L, Bledsoe G, Chao L, Chao J. Intermedin is a new angiogenic growth factor. American Journal of Physiology. Heart and Circulatory Physiology. 297: H1040-7. PMID 19592612 DOI: 10.1152/ajpheart.00404.2009  0.76
2008 Hagiwara M, Bledsoe G, Yang ZR, Smith RS, Chao L, Chao J. Intermedin ameliorates vascular and renal injury by inhibition of oxidative stress. American Journal of Physiology. Renal Physiology. 295: F1735-43. PMID 18829738 DOI: 10.1152/ajprenal.90427.2008  0.76
2008 Chao J, Yin H, Gao L, Hagiwara M, Shen B, Yang ZR, Chao L. Tissue kallikrein elicits cardioprotection by direct kinin b2 receptor activation independent of kinin formation. Hypertension. 52: 715-20. PMID 18768400 DOI: 10.1161/HYPERTENSIONAHA.108.114587  0.76
2008 Gao L, Yin H, S Smith R, Chao L, Chao J. Role of kallistatin in prevention of cardiac remodeling after chronic myocardial infarction. Laboratory Investigation; a Journal of Technical Methods and Pathology. 88: 1157-66. PMID 18762777 DOI: 10.1038/labinvest.2008.85  0.76
2008 Yao YY, Yin H, Shen B, Smith RS, Liu Y, Gao L, Chao L, Chao J. Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway. Cardiovascular Research. 80: 354-64. PMID 18689794 DOI: 10.1093/cvr/cvn223  0.76
2008 Smith RS, Gao L, Chao L, Chao J. Tissue kallikrein and kinin infusion promotes neovascularization in limb ischemia. Biological Chemistry. 389: 725-30. PMID 18627294 DOI: 10.1515/BC.2008.084  0.76
2008 Hagiwara M, Shen B, Chao L, Chao J. Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation. Human Gene Therapy. 19: 807-19. PMID 18554097 DOI: 10.1089/hgt.2008.016  0.76
2008 Shen B, Hagiwara M, Yao YY, Chao L, Chao J. Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress. Hypertension. 51: 1358-65. PMID 18391098 DOI: 10.1161/HYPERTENSIONAHA.107.108514  0.76
2008 Bledsoe G, Shen B, Yao YY, Hagiwara M, Mizell B, Teuton M, Grass D, Chao L, Chao J. Role of tissue kallikrein in prevention and recovery of gentamicin-induced renal injury. Toxicological Sciences : An Official Journal of the Society of Toxicology. 102: 433-43. PMID 18227104 DOI: 10.1093/toxsci/kfn008  0.76
2008 Hsu TS, Chen C, Lee PT, Chiu SJ, Liu HF, Tsai CC, Chao JI. 7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway. Cancer Chemotherapy and Pharmacology. 62: 799-808. PMID 18193228 DOI: 10.1007/s00280-007-0667-5  0.52
2008 Yin H, Chao L, Chao J. Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion. Life Sciences. 82: 156-65. PMID 18068196 DOI: 10.1016/j.lfs.2007.10.021  0.76
2007 Wang CR, Chen SY, Shiau AL, Wu CL, Jou IM, Chao L, Chao J. Upregulation of kallistatin expression in rheumatoid joints. The Journal of Rheumatology. 34: 2171-6. PMID 17937475  0.76
2007 Yao YY, Yin H, Shen B, Chao L, Chao J. Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction. Journal of Cardiac Failure. 13: 588-96. PMID 17826650 DOI: 10.1016/j.cardfail.2007.04.009  0.76
2007 Yin H, Chao J, Bader M, Chao L. Differential role of kinin B1 and B2 receptors in ischemia-induced apoptosis and ventricular remodeling. Peptides. 28: 1383-9. PMID 17644219 DOI: 10.1016/j.peptides.2007.05.010  0.76
2007 Yuan G, Deng J, Wang T, Zhao C, Xu X, Wang P, Voltz JW, Edin ML, Xiao X, Chao L, Chao J, Zhang XA, Zeldin DC, Wang DW. Tissue kallikrein reverses insulin resistance and attenuates nephropathy in diabetic rats by activation of phosphatidylinositol 3-kinase/protein kinase B and adenosine 5'-monophosphate-activated protein kinase signaling pathways. Endocrinology. 148: 2016-26. PMID 17272402 DOI: 10.1210/en.2006-0602  0.76
2007 Chao J, Li HJ, Yao YY, Shen B, Gao L, Bledsoe G, Chao L. Kinin infusion prevents renal inflammation, apoptosis, and fibrosis via inhibition of oxidative stress and mitogen-activated protein kinase activity. Hypertension. 49: 490-7. PMID 17224475 DOI: 10.1161/01.HYP.0000255925.01707.eb  0.76
2007 Yao YY, Yin H, Shen B, Chao L, Chao J. Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction. Regulatory Peptides. 140: 12-20. PMID 17196272 DOI: 10.1016/j.regpep.2006.11.020  0.76
2007 Li HJ, Yin H, Yao YY, Shen B, Bader M, Chao L, Chao J. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation. Cardiovascular Research. 73: 130-42. PMID 17137568 DOI: 10.1016/j.cardiores.2006.10.014  0.76
2006 Chao J, Yin H, Yao YY, Shen B, Smith RS, Chao L. Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation. Human Gene Therapy. 17: 1201-13. PMID 17081080 DOI: 10.1089/hum.2006.17.1201  0.76
2006 Chao J, Bledsoe G, Yin H, Chao L. The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction. Biological Chemistry. 387: 665-75. PMID 16800727 DOI: 10.1515/BC.2006.085  0.76
2006 Bledsoe G, Shen B, Yao Y, Zhang JJ, Chao L, Chao J. Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery. Human Gene Therapy. 17: 545-55. PMID 16716111 DOI: 10.1089/hum.2006.17.545  0.76
2006 Chen LM, Wang C, Chen M, Marcello MR, Chao J, Chao L, Chai KX. Prostasin attenuates inducible nitric oxide synthase expression in lipopolysaccharide-induced urinary bladder inflammation. American Journal of Physiology. Renal Physiology. 291: F567-77. PMID 16638913 DOI: 10.1152/ajprenal.00047.2006  0.76
2006 Xia CF, Smith RS, Shen B, Yang ZR, Borlongan CV, Chao L, Chao J. Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor. Hypertension. 47: 752-61. PMID 16534002 DOI: 10.1161/01.HYP.0000214867.35632.0e  0.76
2006 Xia CF, Yin H, Yao YY, Borlongan CV, Chao L, Chao J. Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis. Human Gene Therapy. 17: 206-19. PMID 16454654 DOI: 10.1089/hum.2006.17.206  0.76
2006 Bledsoe G, Crickman S, Mao J, Xia CF, Murakami H, Chao L, Chao J. Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 21: 624-33. PMID 16401625 DOI: 10.1093/ndt/gfi225  0.76
2006 Chao J, Chao L. Experimental therapy with tissue kallikrein against cerebral ischemia. Frontiers in Bioscience : a Journal and Virtual Library. 11: 1323-7. PMID 16368519  0.76
2006 Xia CF, Yin H, Borlongan CV, Chao J, Chao L. Postischemic infusion of adrenomedullin protects against ischemic stroke by inhibiting apoptosis and promoting angiogenesis. Experimental Neurology. 197: 521-30. PMID 16343485 DOI: 10.1016/j.expneurol.2005.10.027  0.76
2005 Hua H, Zhou S, Liu Y, Wang Z, Wan C, Li H, Chen C, Li G, Zeng C, Chen L, Chao L, Chao J. Relationship between the regulatory region polymorphism of human tissue kallikrein gene and essential hypertension. Journal of Human Hypertension. 19: 715-21. PMID 15905889 DOI: 10.1038/sj.jhh.1001875  0.76
2005 Xia CF, Bledsoe G, Chao L, Chao J. Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats. American Journal of Physiology. Renal Physiology. 289: F622-31. PMID 15886273 DOI: 10.1152/ajprenal.00427.2004  0.76
2005 Montanari D, Yin H, Dobrzynski E, Agata J, Yoshida H, Chao J, Chao L. Kallikrein gene delivery improves serum glucose and lipid profiles and cardiac function in streptozotocin-induced diabetic rats. Diabetes. 54: 1573-80. PMID 15855348  0.76
2005 Wang CR, Chen SY, Wu CL, Liu MF, Jin YT, Chao L, Chao J. Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation. Arthritis and Rheumatism. 52: 1319-24. PMID 15818689 DOI: 10.1002/art.20991  0.76
2005 Smith RS, Agata J, Xia CF, Chao L, Chao J. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction. Life Sciences. 76: 2457-71. PMID 15763077 DOI: 10.1016/j.lfs.2004.11.028  0.76
2005 Chao J, Chao L. Kallikrein-kinin in stroke, cardiovascular and renal disease. Experimental Physiology. 90: 291-8. PMID 15653716 DOI: 10.1113/expphysiol.2004.028464  0.76
2005 Yin H, Chao L, Chao J. Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways. The Journal of Biological Chemistry. 280: 8022-30. PMID 15611141 DOI: 10.1074/jbc.M407179200  0.76
2004 Xia CF, Yin H, Borlongan CV, Chao J, Chao L. Adrenomedullin gene delivery protects against cerebral ischemic injury by promoting astrocyte migration and survival. Human Gene Therapy. 15: 1243-54. PMID 15684700 DOI: 10.1089/hum.2004.15.1243  0.76
2004 Zhang JJ, Bledsoe G, Kato K, Chao L, Chao J. Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress. Kidney International. 66: 722-32. PMID 15253727 DOI: 10.1111/j.1523-1755.2004.00794.x  0.76
2004 Chen LG, Wang ZR, Wan CM, Chao L, Chao J, Xing HY. Encapsulated transgene cells attenuate hypertension, cardiac hypertrophy and enhance renal function in Goldblatt hypertensive rats. The Journal of Gene Medicine. 6: 786-97. PMID 15241786 DOI: 10.1002/jgm.563  0.76
2004 Wang T, Li H, Zhao C, Chen C, Li J, Chao J, Chao L, Xiao X, Wang DW. Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries. Gene Therapy. 11: 1342-50. PMID 15175642 DOI: 10.1038/sj.gt.3302294  0.76
2004 Porcu P, Emanueli C, Desortes E, Marongiu GM, Piredda F, Chao L, Chao J, Madeddu P. Circulating tissue kallikrein levels correlate with severity of carotid atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 24: 1104-10. PMID 15072994 DOI: 10.1161/01.ATV.0000128126.57688.a9  0.76
2004 Chao JC, Tseng HP, Chang CW, Chien YY, Au HK, Chen JR, Chen CF. Chicken extract affects colostrum protein compositions in lactating women. The Journal of Nutritional Biochemistry. 15: 37-44. PMID 14711459  0.36
2004 Xia CF, Yin H, Borlongan CV, Chao L, Chao J. Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis. Hypertension. 43: 452-9. PMID 14698996 DOI: 10.1161/01.HYP.0000110905.29389.e5  0.76
2004 Yin H, Chao L, Chao J. Adrenomedullin protects against myocardial apoptosis after ischemia/reperfusion through activation of Akt-GSK signaling. Hypertension. 43: 109-16. PMID 14662648 DOI: 10.1161/01.HYP.0000103696.60047.55  0.76
2003 Zhao C, Wang P, Xiao X, Chao J, Chao L, Wang DW, Zeldin DC. Gene therapy with human tissue kallikrein reduces hypertension and hyperinsulinemia in fructose-induced hypertensive rats. Hypertension. 42: 1026-33. PMID 14568997 DOI: 10.1161/01.HYP.0000097603.55404.35  0.76
2003 Kawasaki K, Smith RS, Hsieh CM, Sun J, Chao J, Liao JK. Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis. Molecular and Cellular Biology. 23: 5726-37. PMID 12897144  0.44
2003 Bledsoe G, Chao L, Chao J. Kallikrein gene delivery attenuates cardiac remodeling and promotes neovascularization in spontaneously hypertensive rats. American Journal of Physiology. Heart and Circulatory Physiology. 285: H1479-88. PMID 12816755 DOI: 10.1152/ajpheart.01129.2002  0.76
2003 Kato K, Yin H, Agata J, Yoshida H, Chao L, Chao J. Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion. American Journal of Physiology. Heart and Circulatory Physiology. 285: H1506-14. PMID 12805025 DOI: 10.1152/ajpheart.00270.2003  0.76
2003 Miao RQ, Chen V, Chao L, Chao J. Structural elements of kallistatin required for inhibition of angiogenesis. American Journal of Physiology. Cell Physiology. 284: C1604-13. PMID 12734113 DOI: 10.1152/ajpgi.00524.2002  0.76
2003 Agata J, Zhang JJ, Chao J, Chao L. Adrenomedullin gene delivery inhibits neointima formation in rat artery after balloon angioplasty. Regulatory Peptides. 112: 115-20. PMID 12667632  0.76
2003 Wang C, Chao J, Chao L. Adenovirus-mediated human prostasin gene delivery is linked to increased aldosterone production and hypertension in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 284: R1031-6. PMID 12626364 DOI: 10.1152/ajpregu.00660.2002  0.76
2003 Ni A, Yin H, Agata J, Yang Z, Chao L, Chao J. Overexpression of kinin B1 receptors induces hypertensive response to des-Arg9-bradykinin and susceptibility to inflammation. The Journal of Biological Chemistry. 278: 219-25. PMID 12411434 DOI: 10.1074/jbc.M209490200  0.76
2002 Chao J, Chao L. The Role of Adrenomedullin in Cardiovascular and Renal Function. Drug News & Perspectives. 15: 511-518. PMID 12677190  0.76
2002 Dobrzynski E, Montanari D, Agata J, Zhu J, Chao J, Chao L. Adrenomedullin improves cardiac function and prevents renal damage in streptozotocin-induced diabetic rats. American Journal of Physiology. Endocrinology and Metabolism. 283: E1291-8. PMID 12424108 DOI: 10.1152/ajpendo.00147.2002  0.76
2002 Agata J, Chao L, Chao J. Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction. Hypertension. 40: 653-9. PMID 12411458 DOI: 10.1161/01.HYP.0000036035.41122.99  0.76
2002 Miao RQ, Agata J, Chao L, Chao J. Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood. 100: 3245-52. PMID 12384424 DOI: 10.1182/blood-2002-01-0185  0.76
2002 Emanueli C, Salis MB, Pinna A, Stacca T, Milia AF, Spano A, Chao J, Chao L, Sciola L, Madeddu P. Prevention of diabetes-induced microangiopathy by human tissue kallikrein gene transfer. Circulation. 106: 993-9. PMID 12186806  0.76
2002 Smith RS, Lin KF, Agata J, Chao L, Chao J. Human endothelial nitric oxide synthase gene delivery promotes angiogenesis in a rat model of hindlimb ischemia. Arteriosclerosis, Thrombosis, and Vascular Biology. 22: 1279-85. PMID 12171788  0.76
2002 Thongboonkerd V, Gozal E, Sachleben LR, Arthur JM, Pierce WM, Cai J, Chao J, Bader M, Pesquero JB, Gozal D, Klein JB. Proteomic analysis reveals alterations in the renal kallikrein pathway during hypoxia-induced hypertension. The Journal of Biological Chemistry. 277: 34708-16. PMID 12121987 DOI: 10.1074/jbc.M203799200  0.76
2002 Chao J, Wang C, Chao L. Adenovirus-mediated gene transfer for cardiovascular and renal diseases. Methods in Enzymology. 346: 247-63. PMID 11883071 DOI: 10.1016/S0076-6879(02)46047-8  0.76
2002 Yu H, Song Q, Freedman BI, Chao J, Chao L, Rich SS, Bowden DW. Association of the tissue kallikrein gene promoter with ESRD and hypertension. Kidney International. 61: 1030-9. PMID 11849458 DOI: 10.1046/j.1523-1755.2002.00198.x  0.76
2002 Narikiyo T, Kitamura K, Adachi M, Miyoshi T, Iwashita K, Shiraishi N, Nonoguchi H, Chen LM, Chai KX, Chao J, Tomita K. Regulation of prostasin by aldosterone in the kidney. The Journal of Clinical Investigation. 109: 401-8. PMID 11828000 DOI: 10.1172/JCI13229  0.4
2002 Porcu P, Emanueli C, Kapatsoris M, Chao J, Chao L, Madeddu P. Reversal of angiogenic growth factor upregulation by revascularization of lower limb ischemia. Circulation. 105: 67-72. PMID 11772878  0.76
2002 Donaldson SH, Hirsh A, Li DC, Holloway G, Chao J, Boucher RC, Gabriel SE. Regulation of the epithelial sodium channel by serine proteases in human airways. The Journal of Biological Chemistry. 277: 8338-45. PMID 11756432 DOI: 10.1074/jbc.M105044200  0.76
2001 Chao J, Kato K, Zhang JJ, Dobrzynski E, Wang C, Agata J, Chao L. Human adrenomedullin gene delivery protects against cardiovascular remodeling and renal injury. Peptides. 22: 1731-7. PMID 11754958  0.76
2001 Wolf WC, Evans DM, Chao L, Chao J. A synthetic tissue kallikrein inhibitor suppresses cancer cell invasiveness. The American Journal of Pathology. 159: 1797-805. PMID 11696440 DOI: 10.1016/S0002-9440(10)63026-X  0.76
2001 Chao J, Miao RQ, Chen V, Chen LM, Chao L. Novel roles of kallistatin, a specific tissue kallikrein inhibitor, in vascular remodeling. Biological Chemistry. 382: 15-21. PMID 11258665 DOI: 10.1515/BC.2001.003  0.76
2000 Agata J, Miao RQ, Yayama K, Chao L, Chao J. Bradykinin B(1) receptor mediates inhibition of neointima formation in rat artery after balloon angioplasty. Hypertension. 36: 364-70. PMID 10988266  0.76
2000 Zhang JJ, Yoshida H, Chao L, Chao J. Human adrenomedullin gene delivery protects against cardiac hypertrophy, fibrosis, and renal damage in hypertensive dahl salt-sensitive rats. Human Gene Therapy. 11: 1817-27. PMID 10986555 DOI: 10.1089/10430340050129440  0.76
2000 Wolf WC, Yoshida H, Agata J, Chao L, Chao J. Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure. Kidney International. 58: 730-9. PMID 10916096 DOI: 10.1046/j.1523-1755.2000.00219.x  0.76
2000 Emanueli C, Salis MB, Chao J, Chao L, Agata J, Lin KF, Munaò A, Straino S, Minasi A, Capogrossi MC, Madeddu P. Adenovirus-mediated human tissue kallikrein gene delivery inhibits neointima formation induced by interruption of blood flow in mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 20: 1459-66. PMID 10845858  0.76
2000 Miao RQ, Murakami H, Song Q, Chao L, Chao J. Kallistatin stimulates vascular smooth muscle cell proliferation and migration in vitro and neointima formation in balloon-injured rat artery. Circulation Research. 86: 418-24. PMID 10700446  0.76
2000 Yoshida H, Zhang JJ, Chao L, Chao J. Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Hypertension. 35: 25-31. PMID 10642270  0.76
1999 Murakami H, Miao RQ, Chao L, Chao J. Adenovirus-mediated kallikrein gene transfer inhibits neointima formation via increased production of nitric oxide in rat artery. Immunopharmacology. 44: 137-43. PMID 10604537  0.76
1999 Zhang JJ, Wang C, Lin KF, Chao L, Chao J. Human tissue kallikrein attenuates hypertension and secretes into circulation and urine after intramuscular gene delivery in hypertensive rats. Clinical and Experimental Hypertension (New York, N.Y. : 1993). 21: 1145-60. PMID 10513833  0.76
1999 Zhang JJ, Chao L, Chao J. Adenovirus-mediated kallikrein gene delivery reduces aortic thickening and stroke-induced death rate in Dahl salt-sensitive rats. Stroke; a Journal of Cerebral Circulation. 30: 1925-31; discussion . PMID 10471446  0.76
1999 Murakami H, Yayama K, Miao RQ, Wang C, Chao L, Chao J. Kallikrein gene delivery inhibits vascular smooth muscle cell growth and neointima formation in the rat artery after balloon angioplasty. Hypertension. 34: 164-70. PMID 10454435  0.76
1999 Emanueli C, Chao J, Regoli D, Chao L, Ni A, Madeddu P. The bradykinin B1 receptor and the central regulation of blood pressure in spontaneously hypertensive rats. British Journal of Pharmacology. 126: 1769-76. PMID 10372819 DOI: 10.1038/sj.bjp.0702527  0.76
1999 Lin KF, Chao J, Chao L. Atrial natriuretic peptide gene delivery reduces stroke-induced mortality rate in Dahl salt-sensitive rats. Hypertension. 33: 219-24. PMID 9931108  0.76
1999 Wolf WC, Harley RA, Sluce D, Chao L, Chao J. Localization and expression of tissue kallikrein and kallistatin in human blood vessels. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 47: 221-8. PMID 9889257  0.76
1998 Wolf WC, Harley RA, Sluce D, Chao L, Chao J. Cellular localization of kallistatin and tissue kallikrein in human pancreas and salivary glands. Histochemistry and Cell Biology. 110: 477-84. PMID 9826127  0.76
1998 Ni A, Chai KX, Chao L, Chao J. Molecular cloning and expression of rat bradykinin B1 receptor. Biochimica Et Biophysica Acta. 1442: 177-85. PMID 9804950 DOI: 10.1016/S0167-4781(98)00163-8  0.76
1998 Chao J, Zhang JJ, Lin KF, Chao L. Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats. Kidney International. 54: 1250-60. PMID 9767541 DOI: 10.1046/j.1523-1755.1998.00104.x  0.76
1998 Stadnicki A, Chao J, Stadnicka I, Van Tol E, Lin KF, Li F, Sartor RB, Colman RW. Localization and secretion of tissue kallikrein in peptidoglycan-induced enterocolitis in Lewis rats. The American Journal of Physiology. 275: G854-61. PMID 9756518  0.76
1998 Lin KF, Chao J, Chao L. Atrial natriuretic peptide gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in salt-sensitive rats. Human Gene Therapy. 9: 1429-38. PMID 9681414 DOI: 10.1089/hum.1998.9.10-1429  0.76
1998 Chao J, Zhang JJ, Lin KF, Chao L. Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats. Human Gene Therapy. 9: 21-31. PMID 9458239 DOI: 10.1089/hum.1998.9.1-21  0.76
1998 Ni A, Chao L, Chao J. Transcription factor nuclear factor kappaB regulates the inducible expression of the human B1 receptor gene in inflammation. The Journal of Biological Chemistry. 273: 2784-91. PMID 9446586 DOI: 10.1074/jbc.273.5.2784  0.76
1997 Chao J, Jin L, Lin KF, Chao L. Adrenomedullin gene delivery reduces blood pressure in spontaneously hypertensive rats. Hypertension Research : Official Journal of the Japanese Society of Hypertension. 20: 269-77. PMID 9453262  0.76
1997 Jin L, Zhang JJ, Chao L, Chao J. Gene therapy in hypertension: adenovirus-mediated kallikrein gene delivery in hypertensive rats. Human Gene Therapy. 8: 1753-61. PMID 9358025 DOI: 10.1089/hum.1997.8.15-1753  0.76
1997 Chai KX, Chen VC, Ni A, Lindpaintner K, Rubattu S, Chao L, Chao J. Molecular cloning and expression of rat kallistatin gene. Biochimica Et Biophysica Acta. 1353: 277-86. PMID 9349723  0.76
1997 Lin KF, Chao L, Chao J. Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery. Hypertension. 30: 307-13. PMID 9314409  0.76
1997 Chao J, Yang Z, Jin L, Lin KF, Chao L. Kallikrein gene therapy in newborn and adult hypertensive rats. Canadian Journal of Physiology and Pharmacology. 75: 750-6. PMID 9276159  0.76
1997 Chao JR, Chen CS, Wang TF, Tseng LH, Tsai JJ, Kuo ML, Yen JJ, Yang Yen HF. Characterization of factor-independent variants derived from TF-1 hematopoietic progenitor cells: the role of the Raf/MAP kinase pathway in the anti-apoptotic effect of GM-CSF. Oncogene. 14: 721-8. PMID 9038380 DOI: 10.1038/sj.onc.1200884  0.8
1996 Chai KX, Ni A, Wang D, Ward DC, Chao J, Chao L. Genomic DNA sequence, expression, and chromosomal localization of the human B1 bradykinin receptor gene BDKRB1. Genomics. 31: 51-7. PMID 8808279 DOI: 10.1006/geno.1996.0008  0.76
1995 Chi KH, Chen CH, Chan WK, Chow KC, Chen SY, Yen SH, Chao JY, Chang CY, Chen KY. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 13: 2620-8. PMID 7595716  0.72
1995 Lin KF, Chao J, Chao L. Human atrial natriuretic peptide gene delivery reduces blood pressure in hypertensive rats. Hypertension. 26: 847-53. PMID 7490138  0.76
Show low-probability matches.